Atlas.
Sign inStart free trial
IDXXNASDAQ · US

IDEXX LABORATORIES INC /DE

Technology · In Vitro & In Vivo Diagnostic Substances

TechnologyIn Vitro & In Vivo Diagnostic Substances
CEO
—
Founded
—
IPO Date
—
HQ
Westbrook, ME, United States
Exchange
NASDAQ
Employees
n.a.

Share Price Performance

$537.58 ▼ 19.8%
Last (1 Jul 2026) · $538
Period High · $724.76
Period Low · $526.44
52W: $514.61 – $766.68

Key Metrics

Share Price
$537.58
+2.1% today
Market Cap
$42.9B
P / E
40.5x
EV / Revenue
10.1x
Revenue Growth
+10.4%
year-on-year
Gross Margin
+61.8%
Enterprise Value
$43.3B
52W High
$766.68
52W Low
$514.61
Avg Volume
601K
daily

Sources: SEC filings · Market data as of Jul 6, 2026

Shareholders' Structure
13 known institutional holders·$3.2B total on record·2026-Q1
BlackRock, Inc.
7.1%·$1.1B
State Street Corp
4.0%·$608M
Geode Capital Management, LLC
2.6%·$395M
Invesco Ltd.
2.0%·$308M
Bank Of America Corp
1.4%·$207M
Point72 Asset Management, L.P.
1.0%·$157M
Dimensional Fund Advisors LP
1.0%·$155M
Northern Trust Corp
0.9%·$143M
Jpmorgan Chase & Co
0.6%·$85M
Goldman Sachs Group Inc
0.4%·$60M
Fmr LLC
0.2%·$36M
Price T Rowe Associates Inc
0.2%·$31,887
Renaissance Technologies LLC
0.1%·$16M
Free Float
78.3%

Sources: SEC filings

Notes: % shown as share of total shares outstanding · Free float = shares outstanding minus all known 13F institutional holdings

What Atlas covers for IDEXX LABORATORIES INC /DE
OverviewIDEXX LABORATORIES INC /DE share price history (10 years), key market statistics, and institutional shareholder structure from SEC 13F-HR filings.Business ModelHow IDEXX LABORATORIES INC /DE generates revenue — product and service segments, geographic breakdown, key operating metrics, and 10-year business evolution sourced from SEC filings.FinancialsIDEXX LABORATORIES INC /DE's complete financial history — 10 years of annual revenue, gross margins, operating income, net income, EPS, and free cash flow from SEC filings, plus 12 quarters of quarterly results.Management QualityIDEXX LABORATORIES INC /DE executive team profiles, insider buying and selling from SEC Form 4, earnings call transcripts, and a track record of guidance delivery vs actual results.Risk FactorsIDEXX LABORATORIES INC /DE's annual risk disclosures from SEC filings — full text, 5-year evolution showing how risks have shifted, and year-on-year delta highlighting new and removed risks.NewsAI-synthesised news digest for IDEXX LABORATORIES INC /DE, updated regularly with key developments, earnings updates, product announcements, and material company events.SentimentInvestor sentiment for IDEXX LABORATORIES INC /DE aggregated from X.com, Reddit, and Hacker News — discussion themes, Bull and Bear signals, and community analysis.Valuation & PeersIDEXX LABORATORIES INC /DE valuation multiples — P/E, EV/Revenue, EV/EBITDA — compared against a curated set of industry peers using live data from SEC filings. Custom peer selection available.DCF BuilderBuild a discounted cash flow model for IDEXX LABORATORIES INC /DE with 10 years of pre-filled revenue, margins, and cash flow data from SEC filings. Adjust growth rates, WACC, and terminal assumptions.Atlas AnalysisAtlas AI research synthesis for IDEXX LABORATORIES INC /DE — business model, financial health, management quality, risk profile, and institutional ownership, grounded exclusively in SEC filings.

Unlock the full analysis

9-tab institutional research sourced directly from SEC filings. No tips, no scores — the same process professional investors use.

7-day free trial · Plus & Pro · No charge during trial